These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8762493)

  • 1. [Four cases of similar Hexheimer's reaction during the initial chemotherapy for tuberculosis bacillus].
    Lu H; Wu H; Liang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Dec; 18(6):348-50, 382-3. PubMed ID: 8762493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of childhood tuberculosis.
    Indian Pediatr; 1998 Aug; 35(8):816-9. PubMed ID: 10216589
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
    Mofredj A; Guérin JM; Leibinger F; Masmoudi R
    Infection; 1996; 24(5):390-1. PubMed ID: 8923052
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intradermal reaction to tuberculin: application, interpretation and therapeutic implications].
    Van Vooren JP
    Rev Med Brux; 2000 Feb; 21(1):A45-8. PubMed ID: 10748688
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data].
    Iukhimenko NV
    Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple small bowel perforations in a patient on treatment of tuberculosis.
    Scriven JM; Berry D
    J R Coll Surg Edinb; 1996 Oct; 41(5):353. PubMed ID: 8908966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fulminant hepatitis during the therapy for tuberculous meningitis].
    Garavelli PL
    Recenti Prog Med; 1996 Dec; 87(12):597. PubMed ID: 9102699
    [No Abstract]   [Full Text] [Related]  

  • 20. Another step on the path to better TB therapies.
    Vernon A; Burman W; Horsburgh CR
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):1-2. PubMed ID: 11931394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.